Dyslipidemia Trials in San Antonio, United States
Conditions / Dyslipidemia / San Antonio, United States
Dyslipidemia has been the subject of sustained clinical investigation across multiple research sites.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00412113 | A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk | COMPLETED | PHASE4 |
| NCT00463606 | A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia | COMPLETED | PHASE3 |
| NCT00616772 | Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood | COMPLETED | PHASE3 |
| NCT02867813 | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension | COMPLETED | PHASE3 |
| NCT00267254 | A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol. | COMPLETED | PHASE3 |
| NCT01764633 | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk | COMPLETED | PHASE3 |
| NCT00267267 | A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. | TERMINATED | PHASE3 |
| NCT00487994 | Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia | COMPLETED | PHASE3 |
| NCT03071692 | Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) | TERMINATED | PHASE3 |
| NCT00017953 | Look AHEAD: Action for Health in Diabetes | COMPLETED | NA |